Abstract
Carcinoembryonic antigen (CEA) has been detected by immunohistochemistry in breast carcinoma, but its relationship with prognosis is still unclear. This difficulty may be because of the great variety of antibodies used for its determination. In the present study, 271 stages I and II breast carcinomas are analyzed by immunohistochemistry, using T84.66 antibody, a well-known highly specific CEA antibody. The results show that CEA expression was not associated with any of the clinicopathologic factors analyzed. Factors associated with disease-free survival (DFS) after univariate logistic regression analyses were tumor size smaller than 2 cm (P = .01), lymph node free of metastases (P = .0000), low nuclear grade (P = .007), absence of c-erbB-2 overexpression (P = .02), and bcl-2 (P = .005) and CEA expression (P = .005), whereas those significantly associated with a better overall survival (OS) were tumor size small than 2 cm (P = .002), lymph node free of metastases (P = .0001), low nuclear grade (P = .01), low histological grade (P = .02), absence of c-erbB-2 overexpression (P = .002) and bcl-2 expression (P = .01). After multivariate stepwise regression analysis, lymph node free of metastases (P = .0000), CEA expression (P = .001...Continue Reading
References
Sep 1, 1978·Cancer·D M GoldenbergF J Primus
Nov 1, 1978·Histopathology·S Shousha, T Lyssiotis
Mar 24, 1979·British Medical Journal·S ShoushaP J Scheuer
Nov 1, 1992·Cancer·L P FieldingL S Freedman
Jun 25, 1992·The New England Journal of Medicine·W L McGuire, G M Clark
Oct 15, 1989·Cancer·J F RobertsonR W Blamey
Oct 15, 1989·Cancer·R ColomerL Salvador
Nov 1, 1985·Pathology, Research and Practice·W BöckerH E Stegner
Feb 15, 1985·International Journal of Cancer. Journal International Du Cancer·R HartfielM M Brentani
Jul 15, 1985·Cancer·K W GilchristR A Schinella
Mar 1, 1986·Cancer·M GionG Bruscagnin
May 15, 1985·Cancer·M R SchwartzW B Panko
Oct 1, 1983·Cancer·F P KuhajdaG Mendelsohn
Feb 1, 1984·Cancer·T P WaalkesD S Ettinger
Apr 1, 1983·Cancer·E G MansourM Petrelli
Apr 1, 1980·Journal of Clinical Pathology·R A Walker
Aug 15, 1980·Cancer·E R FisherB Fisher
Mar 1, 1993·Human Pathology·J M EstebanJ E Shively
Sep 1, 1994·Cancer·J M EstebanJ E Shively
Jul 1, 1994·Cancer·E G MansourL Dressler
Apr 6, 1994·Journal of the National Cancer Institute·R SilvestriniU Veronesi
Citations
Apr 6, 2001·Hybridoma·F ZhangK L O'Neill
Nov 16, 2006·Cancer Biotherapy & Radiopharmaceuticals·Anna Maria BerghellaDomenico Adorno
Oct 9, 1998·Journal of Cutaneous Pathology·H InoueA Ishibashi
Nov 24, 2012·The British Journal of Surgery·S SaadatmandP J K Kuppen
Feb 6, 2004·Molecular & Cellular Proteomics : MCP·Jeffrey S RossGabriel N Hortobagyi
Jan 7, 2000·Journal of Cellular Physiology·S MénardS M Pupa
Apr 16, 2002·British Journal of Cancer·F G EbelingD Seidel
Nov 22, 2017·Journal for Immunotherapy of Cancer·Patrick M DillonCraig L Slingluff
May 2, 2009·Clinical and Experimental Medicine·David Siu
Dec 1, 1998·Stem Cells·J S Ross, J A Fletcher
Apr 7, 2009·The Oncologist·Jeffrey S RossGabriel N Hortobagyi
Aug 5, 2003·The Oncologist·Jeffrey S RossKenneth J Bloom
Aug 1, 1997·Cancer Biotherapy & Radiopharmaceuticals·P PellegriniC U Casciani
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Akira OhkiaMark E Stearns
Nov 17, 2020·Oncotarget·Marc B BechmannRené Villadsen
Oct 28, 2004·Archives of Pathology & Laboratory Medicine·Ahwon LeeSang In Shim
Dec 16, 2010·Analytical Chemistry·Rükan GençCiara K O'Sullivan